Accentia Biopharmaceuticals (ABPI) CEO Takes on Second Job as Head of Biovest International, Inc.
3/5/2009 8:16:03 AM
More...
|
Accentia Biopharmaceuticals (ABPI) Reorganization Claims More Jobs
11/24/2008 7:11:49 AM
More...
|
Delisting of Securities of Accentia Biopharmaceuticals (ABPI) From The NASDAQ Stock Market
11/13/2008 10:52:12 PM
More...
|
Accentia Biopharmaceuticals (ABPI) Announces Pending Delisting from NASDAQ
11/4/2008 10:07:38 AM
More...
|
Accentia Biopharmaceuticals (ABPI) to Present at Rodman & Renshaw 10th Annual Healthcare Conference
10/27/2008 11:18:18 AM
More...
|
Skepticism Tempers Cancer Treatment Study Results, Accentia Biopharmaceuticals (ABPI) Stock
8/25/2008 7:26:40 AM
More...
|
Accentia Biopharmaceuticals (ABPI) Reports Fiscal Third Quarter Financial Results
8/14/2008 11:29:02 PM
More...
|
Accentia Biopharmaceuticals (ABPI) to Present at the Jefferies Second Annual Healthcare Conference
6/24/2008 11:07:36 AM
More...
|
Accentia Biopharmaceuticals (ABPI) Reports on Multiple Sclerosis Study: Revimmune® Shows Unprecedented Results in Reducing Disability and Improving Functions
6/17/2008 2:08:25 PM
More...
|
Accentia Biopharmaceuticals (ABPI) Announces $8.5 Million Financing to Advance Key Strategies for SinuNase(TM) and Revimmune(TM)
6/17/2008 8:41:36 AM
More...
|
|